Early age of onset and familial breast cancer

Genetic susceptibility to non-polyposis colorectal cancer.

Journal of medical genetics·1999

Hereditary colorectal cancer.

Seminars in oncology·1999

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

Journal of the National Cancer Institute·1999

Colorectal cancer in hereditary breast cancer kindreds.

Diseases of the colon and rectum·1999

Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members.

Cancer genetics and cytogenetics·1999

Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.

Diseases of the colon and rectum·1999

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Neuregulin-4 and Emerging Metabolic and Reproductive Biomarkers in Polycystic Ovary Syndrome: A Narrative Review.

Annals of African medicine·2026

An integrated network toxicology and multi-omics framework prioritizes BRCA1 as a testable candidate in benzo[a]pyrene-associated oral cancer.

Frontiers in pharmacology·2026

A systematic review and meta-analysis reveals enrichment of pro-inflammatory and bacterial immunity-modulating taxa in oral squamous cell carcinoma.

Frontiers in immunology·2026

[Insights into the occurrence and heterogeneity of gastric cancer from the perspective of clinical data integration].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2026

Codon Usage Bias Analysis in Oral Cancer: Comprehensive Molecular and Evolutionary Insights.

Frontiers in bioscience (Elite edition)·2026

GHRH and GLP-1 receptor agonism promote human β-cell survival and improve glucose homeostasis in diabetic mice.

Endocrinology·2026

Related Experiment Videos

Early age of onset and familial breast cancer

Related Concept Videos

Genetic susceptibility to non-polyposis colorectal cancer.

Hereditary colorectal cancer.

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

Colorectal cancer in hereditary breast cancer kindreds.

Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members.

Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Neuregulin-4 and Emerging Metabolic and Reproductive Biomarkers in Polycystic Ovary Syndrome: A Narrative Review.

An integrated network toxicology and multi-omics framework prioritizes BRCA1 as a testable candidate in benzo[a]pyrene-associated oral cancer.

A systematic review and meta-analysis reveals enrichment of pro-inflammatory and bacterial immunity-modulating taxa in oral squamous cell carcinoma.

[Insights into the occurrence and heterogeneity of gastric cancer from the perspective of clinical data integration].

Codon Usage Bias Analysis in Oral Cancer: Comprehensive Molecular and Evolutionary Insights.

GHRH and GLP-1 receptor agonism promote human β-cell survival and improve glucose homeostasis in diabetic mice.

Related Experiment Videos

Early age of onset and familial breast cancer

Related Concept Videos

Related Articles